期刊文献+

泊沙康唑晶型制备及甲醇-水体系中相图测定 被引量:1

Preparation of Polymorphs of Posaconazole and Determination of Phase Diagram in Methanol-water System
原文传递
导出
摘要 目的 制备泊沙康唑工艺相关的Form Ⅰ、Form Ⅲ、Form Ⅳ、Form S 4种晶型,研究上述晶型在甲醇-水体系中相互稳定性关系,并绘制相图。方法 采用溶液结晶法控制结晶溶剂、温度等析晶条件进行制备,并采用XRPD、DSC、TGA等方法表征4种晶型,采用晶型竞争试验的方法研究晶型在甲醇-水体系中的相对稳定性。结果 在甲醇-水体系中,泊沙康唑的晶型与水活度及温度密切相关。高水活度和低温更易于形成Form Ⅳ;高浓度甲醇和低温更易于形成Form Ⅲ;高水活度和高温更易于形成Form S;低水活度和高温更易于形成Form Ⅰ。结论 泊沙康唑在原料药结晶工艺及制剂处方工艺过程中存在转晶风险,制剂处方工艺中采用湿法造粒风险较高,因此在结晶工艺过程中确定析晶和洗涤时的甲醇优选范围对原料药和制剂生产过程中的晶型控制具有较强的指导意义。 OBJECTIⅣE To prepare four polymorphs(Form Ⅰ, Form Ⅲ, Form Ⅳ and Form S) related in industry process of posaconazole and to study their relative stability and the phase diagram in methanol-water system. METHODS Solution crystallization method were chosen to produce the forms through controlling solvents, temperature and other crystallization conditons. XRPD, DSC, TGA were used to characterize polymorphs. Competitive ripening were taken to study the relative stability in methanol-water system. RESULTS In methanol-water system, water activity and temperature were both key parameters for crystal controlling. Higher water activity and lower temperature were conducive to Form Ⅳ;higher concentration of methanol and lower temperature were conducive to Form Ⅲ;higher water activity and higher temperature were conducive to Form S;lower water activity and higher temperature were conducive to Form Ⅰ. CONCLUSION Posaconazole has the risk of crystal form transformation in the crystallization process of the raw material drug and the formulation process of the formulation,and the risk of wet granulation in the formulation process is relatively high. Therefore, determining the preferred range of methanol for crystallization and washing during the crystallization process, is useful for the crystal form control in the drug substance and formulation manufactural processes.
作者 李宏名 张娇 吴转 马秋爽 王天明 LI Hongming;ZHANG Jiao;WU Zhuan;MA Qiushuang;WANG Tianming(Sichuan Kelun Pharmaceutical Research Institute Co.,Ltd.,Chengdu 611138,China;Suizhou Central Hospital,Suizhou 441300,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2022年第14期1863-1867,共5页 Chinese Journal of Modern Applied Pharmacy
关键词 泊沙康唑 多晶型 相图 posaconazole polymorphs phase diagram
  • 相关文献

参考文献7

二级参考文献58

  • 1肖生祥.近十年国外上市的皮肤科新药介绍[J].中国医学文摘(皮肤科学),2012,29(1):9-12. 被引量:2
  • 2夏路风,刘蕾,傅得兴.新型广谱三唑类抗真菌药泊沙康唑[J].中国新药杂志,2007,16(15):1226-1231. 被引量:9
  • 3MUNAYYER HK, MANN PA, CHAU AS, et al. Posaconazole is a potent inhibitor of sterol 14α-demethylation in yeasts and molds [J]. AntimicrobAgents Chemother, 2004,48(10) :3690 -3696.
  • 4PFALLER MA, MESSER SA, BOYKEN L,et al. In vitro activities of voriconazole, posaconazole, and fluconazole against 4169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program [ J ]. Diagn Microbiol Infect Dis, 2004, 48 (3) :201 - 205.
  • 5SABATELLI FJ, LEOBENBERG D, MENDRICK A, et al. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against approximately 18, 000 strains of clinically significant yeasts and moulds [ C ]//44th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC, USA. Oct 30-Nov 2, 2004.
  • 6PFALLER MA, MESSER SA, BOYKEN L,et al. Global trends in the antifungal susceptibility of Cryptococcus neoformans ( 1990 to 2004) [J]. J Clin Microbiol, 2005,43(9) : 2163 -2167.
  • 7PAPHITOU NI, OSTROSKY-ZEICHNER L, PAETZNICK VL, et al. In vitro antlfungal susceptibilities of Trichosporon species [ J ]. Antimicrob Agents Chemother, 2002,46 ( 6 ) : 1144 - 1146.
  • 8MARCO F, PFALLER MA, MESSER SA,et al. In vitro activity of a new tfiazole antifungal agent, SCH 56592, against clinical isolates of filamentous fungi [ J ]. Mycopathologia, 1998,141 ( 1 ) : 73 - 77.
  • 9SUN QN, FOTHERGILL AW, MCCARTHY DI, et al. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes [ J]. Antimicrob Agents Chemother,2002, 46 (7) : 1581 - 1582.
  • 10GONZALEZ GM, FOTHERGILL AW, SUTTON DA, et al. In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi [ J ]. Med Mycol, 2005,43 (2) : 281 -284.

共引文献38

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部